BIO

Bio-Rad Laboratories, Inc.NYSEHealthcare

$279.99+0.59%ClosedMarket Cap: $7.56B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2025-10-30	Wells Fargo	—	Equal Weight	—
2025-10-30	Citigroup	—	Buy	—
2025-08-01	RBC Capital	—	Outperform	—
2025-08-01	Wells Fargo	—	Equal Weight	—
2025-06-09	Wells Fargo	—	Equal Weight	—
2025-05-02	RBC Capital	—	Outperform	—
2025-05-02	UBS	—	Buy	—
2025-05-02	Citigroup	—	Buy	—
2025-04-17	Wells Fargo	—	Equal Weight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$10.25	$2.63B	2
Fri Dec 31	$11.57	$2.72B	2
Sun Dec 31	$12.61	$2.81B	1
Mon Dec 31	$14.30	$2.94B	1